- GMP Consulting & Licensing Solutions
- [email protected]
July 13, 2024
Canadians deserve better access to health care services and affordable medicines, regardless of where they live or their ability to pay. However, the health system in […]
July 9, 2024
On July 4, 2024, Health Canada updated the following guidance document: Annex 2 to the Good manufacturing practices guide – Manufacture of biologics (GUI-0027) This revised […]
June 11, 2024
The List of Drugs for an Urgent Public Health Need includes details like brand name, medicinal ingredients, and usage. It also provides information from public health notifications, such as the foreign regulatory authority, import country, and Canadian jurisdiction. Drugs are eligible for import and sale for one year, subject to renewal and ministerial discretion.
June 8, 2024
The Forward Regulatory Plan for 2024 to 2026 outlines Health Canada’s upcoming regulatory initiatives for the next two years, which will be published in the Canada […]
May 1, 2024
US administration is aiming to reclassify marijuana as a less dangerous drug, proposing a shift from its current Schedule I classification alongside heroin and LSD to […]
April 11, 2024
Health Canada has issued recalls for multiple medical devices, flagging concerns over potential risks to the most vulnerable patients. One such device under scrutiny is the […]
April 3, 2024
The federal government has announced $560 million in health-care and long-term care funding for Saskatchewan. This funding, provided through two bilateral agreements, aims to support improvements […]
April 2, 2024
This landmark initiative mandates the publication of comprehensive details pertaining to all “approved (but not marketed)” products within the expansive Drug Product Database, now conveniently accessible […]
April 16, 2023
“More than 46,000 people in Canada die because of tobacco use every year; one Canadian every 11 minutes. These are our friends, family members, and neighbours. […]